161 related articles for article (PubMed ID: 31361873)
1. Cisatracurium dosing in a patient with hyperthermia.
Lim J; Cox J; Nguyen T; Arya R
Am J Health Syst Pharm; 2019 Jul; 76(14):1029-1032. PubMed ID: 31361873
[TBL] [Abstract][Full Text] [Related]
2. The infusion requirements and recovery characteristics of cisatracurium or atracurium in intensive care patients.
Pearson AJ; Harper NJ; Pollard BJ
Intensive Care Med; 1996 Jul; 22(7):694-8. PubMed ID: 8844237
[TBL] [Abstract][Full Text] [Related]
3. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
Newman PJ; Quinn AC; Grounds RM; Hunter JM; Boyd AH; Eastwood NB; Pollard BJ; Pearson AJ; Harper NJ; Beale RJ; Sutjarittam M; Elliot JM; Bion JF
Crit Care Med; 1997 Jul; 25(7):1139-42. PubMed ID: 9233738
[TBL] [Abstract][Full Text] [Related]
4. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
5. Dose requirements and recovery profile of an infusion of cisatracurium during liver transplantation.
Cammu G; Bossuyt G; De Baerdemaeker L; Den Blauwen N; Struys M; Mortier E
J Clin Anesth; 2002 Mar; 14(2):135-9. PubMed ID: 11943528
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
[TBL] [Abstract][Full Text] [Related]
7. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
Riley K; Yampolsky N; Hakma Z; Moussouttas M
Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
[TBL] [Abstract][Full Text] [Related]
8. Prolonged weakness after cisatracurium infusion: a case report.
Davis NA; Rodgers JE; Gonzalez ER; Fowler AA
Crit Care Med; 1998 Jul; 26(7):1290-2. PubMed ID: 9671384
[TBL] [Abstract][Full Text] [Related]
9. Tachyphylaxis associated with continuous cisatracurium versus pancuronium therapy.
Kanji S; Barletta JF; Janisse JJ; Kruse JA; Devlin JW
Pharmacotherapy; 2002 Jul; 22(7):823-30. PubMed ID: 12126215
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Cisatracurium Continuous Infusion Dose in Acute Respiratory Distress Syndrome.
Merkel A; Massey K; Bellamy C; Miano T; Fuchs B; Candeloro C
J Pharm Pract; 2021 Aug; 34(4):600-605. PubMed ID: 31736402
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis.
Baumann MH; McAlpin BW; Brown K; Patel P; Ahmad I; Stewart R; Petrini M
Chest; 2004 Oct; 126(4):1267-73. PubMed ID: 15486392
[TBL] [Abstract][Full Text] [Related]
12. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
Meeder AM; van der Steen MS; Rozendaal A; van Zanten AR
BMJ Case Rep; 2016 Oct; 2016():. PubMed ID: 27698008
[TBL] [Abstract][Full Text] [Related]
13. Effects of cisatracurium in children during halothane-nitrous oxide anesthesia.
Brandom BW; Woelfel SK; Ference A; Dayal B; Cook DR; Kerls S
J Clin Anesth; 1998 May; 10(3):195-9. PubMed ID: 9603588
[TBL] [Abstract][Full Text] [Related]
14. Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass.
Cammu G; Coddens J; Hendrickx J; Deloof T
Br J Anaesth; 2000 May; 84(5):587-90. PubMed ID: 10844834
[TBL] [Abstract][Full Text] [Related]
15. Recovery from neuromuscular blockade after either bolus and prolonged infusions of cisatracurium or rocuronium using either isoflurane or propofol-based anesthetics.
Jellish WS; Brody M; Sawicki K; Slogoff S
Anesth Analg; 2000 Nov; 91(5):1250-5. PubMed ID: 11049917
[TBL] [Abstract][Full Text] [Related]
16. Association Between Train-of-Four Values and Gas Exchange Indices in Moderate to Severe Acute Respiratory Distress Syndrome.
Groetzinger LM; Rivosecchi RM; Kane-Gill SL; Donahoe MP
Ann Pharmacother; 2016 Dec; 50(12):1009-1015. PubMed ID: 27511813
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P
Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869
[TBL] [Abstract][Full Text] [Related]
18. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
[TBL] [Abstract][Full Text] [Related]
19. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
20. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion].
Wen LL; Lin WQ; Zhao WX; Li GC; Bai XH; Xiao JB
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan; 30(1):163-5. PubMed ID: 20118012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
